Prognostic value and long-term variation of high sensitivity troponin T in clinically stable haemodialysis patients.
To provide data on the long-term prognostic relevance and variation of high sensitivity troponin T (hsTnT) in haemodialysis patients. In 238 stable, asymptomatic haemodialysis patients from a single-centre hsTnT was measured at baseline, 18 and 22 months and outcomes assessed for 24 months. Baseline hsTnT was a significant predictor of all cause (+10 ng/l, HR 1.017, 95%CI 1.011-1.023, p<0.0001) and cardiovascular death (HR 1.02, 95%CI 1.013-1.0026, p<0.0001). HsTnT>140 ng/L was a strong predictor of cardiovascular mortality (HR 8.51, 95%CI 1.907-38.032; p<0.0001). HsTnT increased by >50% in less than one-third of patients, and doubled in only 10% of patients, during 18 and 22 months follow up. In clinically stable hemodialysis patients, higher hsTnT was associated with both total and CV mortality. In most patients variation in levels of hsTnT between 18 and 22 months was <50%, and on average the increase in hsTnT was small.